New cholesterol pill shows promise in early safety trial
NCT ID NCT06556745
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 27 times
Summary
This early study tested a new supplement called BKR-017 in 9 adults with high cholesterol who are already taking statins. The goal was to check how the body processes the supplement and if it is safe. Researchers measured butyrate levels in the blood after a single dose and after 7 days of twice-daily dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
Conditions
Explore the condition pages connected to this study.